Disclosures for "Work-up and Counseling for First Evaluation of Cognitive Decline: A Simulation-based Educational Tool and Embedded Learning Results"
-
Dr. Dass has nothing to disclose.
-
An immediate family member of Dr. Chikwem has received personal compensation for serving as an employee of bristol myers squibb. An immediate family member of Dr. Chikwem has stock in Regeneron .
-
Dr. Jagannathan has nothing to disclose.
-
Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
-
Dr. Bell has nothing to disclose.
-
Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
-
Dr. Ghoshal has nothing to disclose.